Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Kyprolis“
Suchtreffer
Begriffe & Kennungen
Kyprolis · 4.8 · Cardiac failure, myocardial infarction and myocardial ischaemia
Eintrag öffnenKyprolis · 4.8 · Cases of hepatic failure, including fatal cases, have been reported in < 1% of subjects in clinical studies wi
Eintrag öffnenKyprolis · 4.8 · Cases of venous thromboembolic events, including deep vein thrombosis and pulmonary embolism with fatal outcom
Eintrag öffnenKyprolis · 4.8 · Description of selected adverse reactions
Eintrag öffnenKyprolis · 4.8 · Dyspnoea
Eintrag öffnenKyprolis · 4.8 · Dyspnoea was reported in approximately 24% of subjects in clinical studies with Kyprolis. The majority of dysp
Eintrag öffnenKyprolis · 4.8 · Elderly patients
Eintrag öffnenKyprolis · 4.8 · For clinical management of cardiac disorders during Kyprolis treatment, see section 4.4.
Eintrag öffnenKyprolis · 4.8 · Hepatic failure
Eintrag öffnenKyprolis · 4.8 · Hypertension including hypertensive crises
Eintrag öffnenKyprolis · 4.8 · Hypertensive crises (hypertensive urgency or hypertensive emergency) have occurred following administration of
Eintrag öffnenKyprolis · 4.8 · In a randomised, open-label, multicentre study in patients receiving Kyprolis 20/56 mg/m2 infused over 30 minu
Eintrag öffnenKyprolis · 4.8 · In clinical studies with Kyprolis, cardiac failure was reported in approximately 5% of subjects (approximately
Eintrag öffnenKyprolis · 4.8 · In study 20160275 (see section 5.1), in which the administration of Kyprolis in combination with daratumumab a
Eintrag öffnenKyprolis · 4.8 · In study 20160275, 47% of the 308 patients who received KdD 20/56 mg/m2 twice weekly were ≥ 65 years of age. I
Eintrag öffnenKyprolis · 4.8 · In study 20160275, opportunistic infections in each treatment group (9.4% in KdD arm and 3.9% in Kd arm) have
Eintrag öffnenKyprolis · 4.8 · In study 20160275, respiratory tract infections reported as serious adverse reactions occurred in each treatme
Eintrag öffnenKyprolis · 4.8 · In study 20160275, secondary primary malignancies in each treatment group (1.9% in KdD arm and 1.3% in Kd arm)
Eintrag öffnenKyprolis · 4.8 · In study 20160275, the incidence of hepatitis B reactivation was 0.6% in the KdD arm versus 0% in the Kd arm.
Eintrag öffnenKyprolis · 4.8 · In study 20160275, the overall incidence of cardiac disorders (any and all grade events) in the subgroup of pa
Eintrag öffnen